Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series

Abstract

Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.